2,4-Dimethoxyamphetamine

Pharmaceutical compound From Wikipedia, the free encyclopedia

2,4-Dimethoxyamphetamine (2,4-DMA), also known as DMA-3, is a psychoactive drug of the phenethylamine and amphetamine families.[1][2] It is one of the dimethoxyamphetamine (DMA) series of positional isomers.[1][2]

Other names2,4-DMA; 2,4-Dimethoxy-α-methylphenethylamine; DMA-3
ATC code
  • None
Quick facts Clinical data, Other names ...
2,4-Dimethoxyamphetamine
Clinical data
Other names2,4-DMA; 2,4-Dimethoxy-α-methylphenethylamine; DMA-3
Routes of
administration
Oral[1]
Drug classSerotonin receptor modulator; Serotonin 5-HT2A receptor agonist; Psychoactive drug; Stimulant, Serotonergic psychedelic; Hallucinogen
ATC code
  • None
Pharmacokinetic data
Duration of action"Short"[1]
Identifiers
  • 1-(2,4-dimethoxyphenyl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H17NO2
Molar mass195.262 g·mol−1
3D model (JSmol)
  • CC(CC1=C(C=C(C=C1)OC)OC)N
  • InChI=1S/C11H17NO2/c1-8(12)6-9-4-5-10(13-2)7-11(9)14-3/h4-5,7-8H,6,12H2,1-3H3
  • Key:DQWOZMUBHQPFFF-UHFFFAOYSA-N
Close

In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists 2,4-DMA's dose as greater than 60 mg orally and its duration as "short".[1][2] At a dose of 60 mg orally, the effects of 2,4-DMA were reported to include definite threshold effects or even a bit more, a lot of amphetamine-like effects, some euphoria, and a psychedelic-like "diffusion of association".[1][2] The drug's effects started to wear off after 3 hours.[1][2] According to Shulgin, 2,4-DMA could be a full stimulant and/or a full psychedelic at sufficiently high doses, but higher doses were not tested.[1]

2,4-DMA has been found to act as a low-potency full agonist of the serotonin 5-HT2A receptor, with an EC50Tooltip half-maximal effective concentration of 2,950 nM and an EmaxTooltip half-maximal effective concentration of 117%.[3] It fully substitutes for DOM in rodent drug discrimination tests.[4][5] The drug is less potent in this regard than 2,4,5-trimethoxyamphetamine (2,4,5-TMA or TMA-2), but is more potent than 3,4,5-trimethoxyamphetamine (3,4,5-TMA or TMA-1).[4] 2,4-DMA fails to produce stimulus generalization to dextroamphetamine in rodent drug discrimination tests, suggesting that it lacks psychostimulant- or amphetamine-like effects.[6]

The chemical synthesis of 2,4-DMA has been described.[1]

2,4-DMA was first described in the scientific literature by Alexander Shulgin and colleagues by at least 1967.[7][8] Subsequently, it was described in greater detail by Shulgin in PiHKAL in 1991.[1]

See also

References

Related Articles

Wikiwand AI